Skip to main content

Pieris Pharmaceuticals, Inc. (PIRS)

NASDAQ: PIRS · IEX Real-Time Price · USD
4.23
-0.09 (-2.08%)
After-hours:Oct 22, 2021 7:58 PM EDT
4.32
-0.09 (-2.04%)
At close: Oct 22, 4:00 PM
Market Cap288.19M
Revenue (ttm)23.73M
Net Income (ttm)-48.35M
Shares Out61.91M
EPS (ttm)-0.85
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume528,641
Open4.37
Previous Close4.41
Day's Range4.23 - 4.41
52-Week Range1.70 - 6.15
Beta1.20
AnalystsStrong Buy
Price Target8.50 (+96.8%)
Est. Earnings DateNov 3, 2021

About PIRS

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin protein-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment o...

IndustryBiotechnology
CEOStephen Yoder
Employees111
Stock ExchangeNASDAQ
Ticker SymbolPIRS
Full Company Profile

Financial Performance

In 2020, PIRS's revenue was $29.32 million, a decrease of -36.64% compared to the previous year's $46.28 million. Losses were -$37.23 million, 46.2% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for PIRS stock is "Strong Buy." The 12-month stock price forecast is 8.50, which is an increase of 96.76% from the latest price.

Price Target
$8.50
(96.76% upside)
Analyst Consensus: Strong Buy

News

7 Penny Stocks to Buy to Sidestep the Noise on Wall Street

With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar. The post 7 Penny Stocks to Buy to Sidestep the Noise on Wall Street appeared fir...

Other symbols:CTRMLGVN
1 day ago - InvestorPlace

2 Penny Stocks That Could Soar Soon

These two tiny drugmakers might be hidden gems.

Other symbols:LPTX
1 week ago - The Motley Fool

3 Biotech Stocks to Watch Now

Biotech companies develop new medicines, vaccines, or medical devices. They use advanced technologies and medical science to do so.

Other symbols:ACADFATE
1 week ago - Benzinga

Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer

BOSTON, MA / ACCESSWIRE / October 6, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol...

2 weeks ago - Accesswire

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON, MA / ACCESSWIRE / September 9, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® techn...

1 month ago - Accesswire

Top Penny Stocks to Watch After the Long Weekend

Are these penny stocks on your watchlist this week? The post Top Penny Stocks to Watch After the Long Weekend appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:BIOLBOXL
1 month ago - PennyStocks

5 Penny Stocks To Watch For September With Upcoming Events

These penny stocks could be in focus as we turn the page on a new month. The post 5 Penny Stocks To Watch For September With Upcoming Events appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols:BLUCTICOBSV
1 month ago - PennyStocks

Which Biotech Stock Will Shock the Market in 2022?

Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?

1 month ago - The Motley Fool

Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor

BOSTON, MA / ACCESSWIRE / August 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol...

1 month ago - Accesswire

Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Misses Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -25.00% and -61.47%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, AUGUST 4, 2021 AT 8:00 AM EDT Announced inhaled program PRS-220 for the treatment of IPF and was selected to receive a Bavarian government grant...

2 months ago - Accesswire

Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team

Tim Demuth, M.D., Ph.D., joins Pieris as Chief Medical Officer Shane Olwill, Ph.D.

2 months ago - Accesswire

Pieris Pharmaceuticals to Host Second Quarter 2021 Investor Call and Provide Corporate Update on August 4, 2021

BOSTON, MA / ACCESSWIRE / July 28, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

2 months ago - Accesswire

Are These 8 Penny Stocks to Watch on Your List Right Now?

Making a penny stocks watchlist for 2021? Check these 8 out The post Are These 8 Penny Stocks to Watch on Your List Right Now?

3 months ago - PennyStocks

This Risky Micro-Cap Could Pay Off Big

Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.

Other symbols:AZNSGEN
3 months ago - The Motley Fool

Pieris Stock Moves Higher On €14.2M Grant For PRS-220 In Post-COVID Pulmonary Fibrosis

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) has announced the development of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor to treat idiopathic pulmonary fibrosis (IP...

3 months ago - Benzinga

Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Doll...

PRS-220, an oral inhaled Anticalin protein targeting CTGF, a fully proprietary drug candidate for respiratory disease, is being developed as a local treatment for idiopathic pulmonary fibrosis Grant to ...

3 months ago - Accesswire

Best Penny Stocks to Buy Right Now? 15 To Watch In July

These penny stocks are trending right now, here's why The post Best Penny Stocks to Buy Right Now? 15 To Watch In July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 months ago - PennyStocks

3 Top Stocks Under $10

Are you looking for cheap stocks with a lot of upside? Check out Rolls-Royce, Pieris Pharmaceuticals, and Kahoot!

3 months ago - The Motley Fool

Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer

BOSTON, MA / ACCESSWIRE / June 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technolog...

3 months ago - Accesswire

Best Biotech Penny Stocks to Buy Next Month? 3 For Your Watchlist

Are these biotech penny stocks to watch on your list for July 2021? The post Best Biotech Penny Stocks to Buy Next Month?

Other symbols:ANPCSESN
4 months ago - PennyStocks

Hot Penny Stocks to Buy? 3 For Your Morning Watchlist

Investing in penny stocks in June? Check these 3 out today The post Hot Penny Stocks to Buy?

Other symbols:DPWRETO
4 months ago - PennyStocks

4 Robinhood Penny Stocks to Watch in Summer 2021

Best Robinhood penny stocks for Summer 2021? Check these 4 out The post 4 Robinhood Penny Stocks to Watch in Summer 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....

Other symbols:CIDMLAIXZOM
4 months ago - PennyStocks

PIRS Stock: The Big News That Has Pieris Pharma Shares Rising Today

Pieris Pharmaceuticals (PIRS) stock is rising higher on Wednesday after announcing a collaboration agreement with Genentech. The post PIRS Stock: The Big News That Has Pieris Pharma Shares Rising Today ...

4 months ago - InvestorPlace

Are Options Traders Betting on a Big Move in Pieris (PIRS) Stock?

Investors need to pay close attention to Pieris (PIRS) stock based on the movements in the options market lately.

4 months ago - Zacks Investment Research